AxoSim, a New Orleans-based life science company focused on neurological disease, announced on Tuesday that it has appointed Stuart Gibb as its new vice president of Sales and Marketing.
In this role Gibb will be responsible for building and leading the sales organisation and strengthening the company's commercial presence.
Gibb has more than 20 years of global sales leadership experience. He has worked as VP of Sales and Marketing at Nortis Biosciences, VP of Global Sales at Araceli Biosciences, VP of Global Sales at Emulate, and held senior sales roles at Thermo Fisher Scientific and Becton Dickinson & Co.
Alif Saleh, AxoSim CEO, said: "We are excited to welcome Stuart as a key member of our team. He has an impressive track record in commercialising and scaling organ-on-a-chip platforms from zero to multi-million-dollar businesses."
Vulcan Two signs five-year ERP licence agreement to support ePharmacy expansion
SportsMed Physical Therapy named Physical Therapy Company of the Year
Ensorcell adds new senior leadership team members
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme